Loading…
Loading…
ILIKF does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for ILIKF and 80,000+ other tickers.
See exactly how ILIKF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ILIKF and 80,000+ other tickers.
Ilika plc is a company that focuses on the development, design, and production of cutting-edge solid-state batteries, which it markets under the Stereax brand. Its primary geographical markets include the United Kingdom, Asia, mainland Europe, and North America. The company's innovative battery solutions find applications across various sectors, such as the industrial Internet of Things (IoT), medical devices, transportation, electric vehicles, and the broader fields of cordless consumer electronics and smart city infrastructure. Ilika plc was established in 2004 and operates from its head office located in Romsey, United Kingdom.
Ilika plc (ILIKF) Q4 2026 Earnings Call Transcript
Ilika PLC (AIM:IKA, OTCQX:ILIKF, FRA:I8A) this week outlined continued commercial progress across its Stereax and Goliath solid-state battery businesses,...
Ilika PLC (AIM:IKA, OTCQX:ILIKF, FRA:I8A) this week outlined continued commercial progress across its Stereax and Goliath solid-state battery businesses, with chief executive Graeme Purdy highlighting the company's transition into revenue generation alongside several commercial catalysts expected over the next 12 to 18 months. Purdy, in an interview in the Proactive studio, said the most significant development for the Stereax business had been its move into commercial production, with Ilika now supplying commercial-grade electrodes to Cirtec for incorporation into the M300 medical device product, which is expected to reach the market later this year.
10am: Dow drops over 600 points at open Selling is dominating early stock trading on Wall Street, with the Dow Jones falling 611 points, or 1.16%, to...
Ilika PLC (AIM:IKA, OTCQX:ILIKF, FRA:I8A) flagged that it is now a revenue-generating business, with initial royalties from its miniature solid-state...